Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-21-001263

Director acquired 40,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

GREER R SCOTT · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-01-05 Exercise or conversion : show line 1 in the form +40,000 $13.80 $552,000 225,674 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-01-05 Exercise or conversion : show line 2 in the form Stock Option −40,000 0 D
Loading xslF345X03/doc4.xml…